JUL 24, 2020 1:13 AM PDT

Profiling Technology Provides Rapid Drug Discovery

WRITTEN BY: Nouran Amin

Rapid drug discovery saves lives and new technology is aiming to do just that in the fight against tuberculosis.

Learn more about tuberculosis (TB):

The technology combines machine learning with high throughput imaging to speed discovery of drugs and fight tuberculosis. Generally speaking, drug discovery requires production of hundreds of derivatives to find the one effective compound. With the new technology dubbed ‘MorphEUS’ (Morphological Evaluation and Understanding of drug Stress), it will provide an inexpensive way on how to target the Mycobcterium tuberculosis (M. tb) bacterium.

"We urgently need shorter, more effective TB therapies, and MorphEUS enables us to screen through drug candidates, see how they actually affect the cell, and learn which drugs have unique ways to kill the M. tb," said Bree Aldridge, associate professor of molecular biology and microbiology at Tufts University School of Medicine.

Findings were published online in the Proceedings of the National Academies of Sciences (PNAS) and describes how MorphEUS was applied to 34 currently available antibiotics for TB and was found to correctly categorize them 94 percent of the time.

"We found that conventional morphological profiling approaches didn't work with M. tb, because the bacterium's inherent response to treatment was extremely variable, and changes in morphology were much less obvious than in bacteria like E. coli," said Trever C. Smith II, co-first author on the paper and a postdoctoral researcher in the Aldridge laboratory.

MorphEUS thrives on morphological profiling when combined with enhanced features sets of machine learning. "With MorphEUS, we used the distribution of staining across a large number of bacilli to learn how each drug acts on M. tb," said Aldridge. "Similarly, we looked at staining intensity and the spread of that brightness across thousands of cells to identify more subtle patterns." The technology can also identify which drugs have off-target or side-effects that may be challenging to determine.

"We expect that the success of MorphEUS in profiling drug action in an organism like M. tb with significant inherent heterogeneity and subtle cytological responsiveness will make it useful in other pathogens and cell types," said Aldridge, who is also a core faculty member of Tufts Center for Integrated Management of Antimicrobial Resistance, member of the immunology and molecular microbiology program faculties at Tufts Graduate School of Biomedical Sciences, and an adjunct associate professor at Tufts University's School of Engineering.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 31, 2022
Drug Discovery & Development
Computer Models Help Find Antibiotics to Fight Drug-Resistant Pathogens
MAY 31, 2022
Computer Models Help Find Antibiotics to Fight Drug-Resistant Pathogens
Antibiotics were a revolutionary tool in the fight against bacterial infections. In recent years, however, the emergence ...
JUN 02, 2022
Coronavirus
Loneliness and social isolation may continue to prolong the COVID-19 pandemic
JUN 02, 2022
Loneliness and social isolation may continue to prolong the COVID-19 pandemic
It has been clear for some time that loneliness and social isolation can lead to increased risks for adverse h ...
JUN 13, 2022
Cancer
Clinical Trial Demonstrates an Amazing 100% Response
JUN 13, 2022
Clinical Trial Demonstrates an Amazing 100% Response
The results of a Clinical Trial for rectal cancer patients published last week in the New England Journal of Medicine co ...
JUL 05, 2022
Immunology
A New Type of Universal Flu Vaccine
JUL 05, 2022
A New Type of Universal Flu Vaccine
Researchers have created a new 'universal' flu vaccine, which is directed against type A influenza viruses. It w ...
JUL 23, 2022
Drug Discovery & Development
No Evidence for Depression and Serotonin Activity Link
JUL 23, 2022
No Evidence for Depression and Serotonin Activity Link
A new review study found that there is no clear evidence that serotonin levels or serotonin activity are responsible for ...
AUG 08, 2022
Immunology
Controls and Calibrators for Measurement Assurance in Flow Cytometry: New Applications and New Requirements
AUG 08, 2022
Controls and Calibrators for Measurement Assurance in Flow Cytometry: New Applications and New Requirements
One of the primary objectives for the application of flow cytometry in any testing environment should be measurement ass ...
Loading Comments...